1. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
   Parham Jabbarzadeh Kaboli et al, 2019, Pharmacological Reports CrossRef
2. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies
   Jianmei Sun et al, 2018, International Journal of Pharmaceutics CrossRef
3. Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy
   Ammad Ahmad Farooqi et al, 2019, Cancers CrossRef
4. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer
   Yu Zhou et al, 2019, Technology in Cancer Research & Treatment CrossRef
5. Drug Candidates for Autoimmune Diseases
   Sabrina Saurin et al, 2022, Pharmaceuticals CrossRef
6. Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells
   Rong Ke et al, 2018, Scientific Reports CrossRef
7. Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis
   Yishan Du et al, 2022, Frontiers in Pharmacology CrossRef
8. Traditional Chinese medicines and their active ingredients sensitize cancer cells to TRAIL-induced apoptosis
   Bingyu Sun et al, 2021, Journal of Zhejiang University-SCIENCE B CrossRef
9. Cyclosporin-A reduced the cytotoxicity of propranolol in HUVECs via p38 MAPK signaling
   Zhong Lv et al, 2022, Medicine CrossRef
10. Baicalin potentiates TRAIL-induced apoptosis through p38 MAPK activation and intracellular reactive oxygen species production
    Lei Zhang et al, 2017, Molecular Medicine Reports CrossRef
11. Electrospun lipid-coated medicated nanocomposites for an improved drug sustained-release profile
    Tao Hai et al, 2019, Materials & Design CrossRef
12. Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression
    Giulia Vanti et al, 2021, Pharmaceutics CrossRef
13. Berberine Alleviates Paclitaxel-Induced Neuropathy
    Ramin Rezaee et al, 2019, Journal of Pharmacopuncture CrossRef
14. Research progress on berberine with a special focus on its oral bioavailability
    Chang-Shun Liu et al, 2016, Fitoterapia CrossRef
15. Pharmacotherapeutic values of berberine: A Chinese herbal medicine for the human cancer management
    Nalini Devarajan et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
16. Current understanding and future prospects on Berberine for anticancer therapy
    Anjana Goel, 2023, Chemical Biology & Drug Design CrossRef
17. Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring
    Priyanka D. Pinky et al, 2021, Heliyon CrossRef
18. DSPE-PEG polymer enhanced berberine absorption specifically in the small intestine of rats through paracellular passway
    Yang Gao et al, 2023, Journal of Pharmacy and Pharmacology CrossRef
19. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
    Chaohe Zhang et al, 2020, Frontiers in Pharmacology CrossRef
20. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
    James A. McCubrey et al, 2017, Aging CrossRef
21. Production and investigation of sustained berberine pellet drug release system
    Y. Gao et al, 2018, Advanced Powder Technology CrossRef
22. Identification of the natural product berberine as an antiviral drug
    Jiping Shao et al, 2020, AMB Express CrossRef
23. Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
    Nalini Devarajan et al, 2021, Phytotherapy Research CrossRef
24. Berberine as an Adjuvant and Sensitizer to Current Chemotherapy
    Alok Chandra Bharti et al, 2018, Role of Nutraceuticals in Chemoresistance to Cancer CrossRef